Thus, using this NGS panel in cfDNA of mCRC patients and following ACMG and AMP guidelines, we were able to frequently identify cancer-associated variants with strong clinical significance in relevant genes, such as KRAS and PIK3CA. The gene discussed is KRAS; the disease is cancer.